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Viral proteins interact with one another during viral replication, assembly, and maturation. Systematic interaction assays
of the hepatitis C virus (HCV) proteins using the yeast two-hybrid method have uncovered a novel interaction between core
and NS5A. This interaction was confirmed by in vitro binding assays, and coimmunoprecipitation in mammalian cells. Core
and NS5A are also colocalized in COS-7 cells. Interestingly, NS5A is cleaved to give specific-size fragments, when core is
coexpressed in mammalian cells. Overexpression of core produced many dying and rounded cells and effects such as DNA
laddering and the truncation of poly(ADP-ribose) polymerase 1 (PARP1), both indicators of apoptosis. These observations led
us to investigate the link between the induction of apoptosis by core and the cleavage of NS5A. The proteolysis of NS5A and
these apoptotic events can be inhibited by caspase inhibitor, Z-VAD, indicating that core induces apoptosis and the cleavage
of NS5A by caspases. In cells infected by the HCV, core may provide the intrinsic apoptotic signal, which produces truncated
forms of NS5A. The biological function of core–NS5A interaction and the downstream effect of NS5A cleavage are discussed.
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INTRODUCTION
The hepatitis C virus (HCV) is a positive-stranded RNA
virus belonging to the Flaviviridae family of viruses. This
virus infects more than 170 million people worldwide,
and the persistence of HCV is one of the major causes of
liver diseases and liver transplants. The ability of HCV to
persist chronically in the liver and lymphocytes is due to
multiple factors, some of which may be contributed by
the interaction of viral proteins with cellular proteins,
thus affecting cellular functions.
The RNA genome of the HCV is translated into a single
polypeptide of 3010 amino acids, which is cleaved by
host or viral proteases to produce the structural proteins,
core, E1, and E2, and the nonstructural proteins, NS2,
NS3, NS4A, NS4B, NS5A, and NS5B. Many studies have
focused on the biological effects of core in cells, partic-
ularly on its activities on transcription regulation, signal
transduction, and cell-cycle regulation. The core protein
is the viral nucleocapsid protein that binds and packages
the viral RNA genome. Core has been shown to form
homomultimers (Matsumoto et al., 1996; Nolandt et al.,
1997), and bacterially expressed HCV core proteins can
efficiently self-assemble in vitro into nucleocapsid-like
particles (Kunkel et al., 2001). In addition, core is able to
interact with the envelope protein, E1 (Lo et al., 1996).
Taken together, these data suggest that core, together
with the envelope proteins, forms the capsid of the HCV.
When expressed in mammalian cells, core is localized in
the cytoplasm, but deletion of the C-terminal hydropho-
bic region causes core to translocate to the nucleus
(Ravaggi et al., 1994; Suzuki et al., 1995). Core interacts
with a myriad of cellular proteins with diverse functions,
including tumor necrosis factor receptor (Zhu et al.,
1998), lymphotoxin  receptor (Matsumoto et al., 1997;
Chen et al., 1997), RNA helicases (Mamiya and Worman,
1999; Owsianka and Patel, 1999; You et al., 1999b), het-
erogeneous ribonucleoprotein K (Hsieh et al., 1998),
p21Waf (Wang et al., 2000), p53 (Lu et al., 1999), and LZIP,
a zinc finger protein (Jin et al., 2000). Since full-length
core is found in the cytoplasm, the role of core on
transcriptional regulation could be indirect, through its
interaction with cytoplasmic proteins and signal trans-
duction pathways (Jin et al., 2000; Kato et al., 2000;
Naganuma et al., 2000; Otsuka et al., 2000), to cause the
transcription or repression of nuclear genes. The appar-
ent opposite effect of core on apoptosis is rather inter-
esting. Core has been reported to regulate apoptosis
positively (Hahn et al., 2000; Honda et al., 2000; Ruggieri
et al., 1997; Zhu et al., 1998) or negatively (Ray et al., 1996,
1998; Marusawa et al., 1999). These discrepancies may
be due to different cell lines and different experimental
regimens employed. In transgenic mice, prolonged core
expression can cause steatosis (Moriya et al., 1997) and
tumorigenesis (Moriya et al., 1998). Steatosis and abnor-
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mal lipid metabolism caused by chronic HCV infection
may be attributed to the association of core protein to
lipid droplets (Moradpour et al., 1996; Barba et al., 1997).
The function of NS5A in viral replication is unknown,
although the convergence of a number of mutations
found in a defined region upstream of the interferon
sensitivity determining region (ISDR) in adapted “repli-
cons” suggests that it is involved in the modulation of
viral replication (Blight et al., 2000). Mutations in the ISDR
in some quasispecies of HCV correlate tightly with the
response of the virus to interferon treatment. This differ-
ential response could be related to the ability of the ISDR
to bind to PKR, thereby inhibiting PKR activity and down-
stream interferon-induced antiviral processes (Gale et
al., 1997). Near the C-terminus is a proline-rich region
that binds Grb2, an SH3-containing protein adaptor pro-
tein involved in signal transduction (Tan et al., 1999). The
C-terminal portion of NS5A can act as a transcription
activator in yeast (Kato et al., 1997) and mammalian cells
(Satoh et al., 2000). NS5A could modulate transcription
through its interaction with a cellular transcription factor,
SRCAP (Ghosh et al., 2000), and protein transport, as it
interacts with a SNARE-like protein (Tu et al., 1999) and
karyopherin 3 (Chung et al., 2000).
Interactions between HCV viral proteins are essential
for the viral replication cycle: nonstructural proteins form
complexes that participate in viral replication, while
structural proteins form the viral envelope during viral
maturation. Viral protein complexes could be involved in
virus–cell interaction as well. We assayed for interaction
between all viral proteins using the yeast two-hybrid
system. Recently, we reported that the NS3–NS3 dimer-
ization is important for optimal helicase activity (Khu et
al., 2001). In this study, we characterized the interaction
between core and NS5A. Core induces apoptosis and
the cleavage of NS5A in mammalian cells when core is
coexpressed. Core could provide an intrinsic apoptotic
signal during HCV infection, and the subsequent trunca-
tion of NS5A. We discuss the possible downstream effect
of the generation of transcriptionally active NS5A forms,
which may activate the expression of genes and contrib-
ute to the pathogenesis of the HCV.
RESULTS
Core–NS5A interaction
We tested for potential interactions between all mature
viral proteins using the yeast two-hybrid assay and found
a positive interaction between core and NS5A. Core
showed interaction with NS5A only, and vice versa. To
determine the minimal region of NS5A and core for this
interaction, deletions of NS5A were made and various
fragments of NS5A tested for interaction with full-length
core using the yeast two-hybrid assay. The minimal re-
gion of NS5A required for interacting with core includes
the PKR-binding, ISDR, and proline-rich regions, stretch-
ing from a.a. 236 to 354 (Fig. 1A). Further truncation of
this minimal fragment abolished interaction with core. An
N-terminally deleted fragment of NS5A activates tran-
scription by itself, consistent with previous studies (Kato
et al., 1997). Other fragments did not self-activate tran-
scription. Similarly, truncations of core were tested for
interaction with full-length NS5A. Deletion of core from
either end abolishes the interaction, indicating that a
full-length core is required for binding to NS5A in the
yeast two-hybrid test (Fig. 1B). All these interaction as-
says were done with core cloned into the pACT2 vector
and NS5A cloned into the pAS2-1 vector, as the NS5A
fused to the activating domain of Gal4 in the pACT2
vector was cytotoxic to yeast cells.
Core and NS5A have each been shown to be localized
to the cytoplasm, but they have not been demonstrated
to be colocalized by immunofluorescence (IF). When
COS-7 cells were singly transfected with constructs ex-
pressing flag-core or myc-NS5A, core shows a punctate
staining pattern around the nucleus, while NS5A is more
closely associated with the nuclear membrane and
tends to be concentrated around one side of the nucleus,
similar to the staining pattern of ER proteins (Fig. 2A).
The staining pattern of each of these two proteins when
coexpressed (Fig. 2B) is somewhat similar to that of the
individual proteins when singly expressed (Fig. 2A).
However, the punctate structures where core is localized
are more dispersed when core is expressed singly than
when core is coexpressed with NS5A. In the presence of
NS5A, core assumes a localization pattern more similar
to that of NS5A, indicating that the two proteins interact.
In addition, the close association of the two proteins is
further confirmed by their overlapping staining pattern by
confocal imaging (Fig. 2B). It should be noted that only a
fraction of NS5A colocalizes with core (Fig. 2B).
The interaction shown by the yeast two-hybrid method
was supported by in vitro binding assays. GST-core-6His
protein was expressed in bacteria and purified by bind-
ing to Ni beads. In vitro translated full-length and
truncated NS5A proteins were added to the GST-core-
6His beads. Two fragments that showed in vitro binding
to immobilized core, the C-terminal fragment of NS5A
(a.a. 147–354) and the minimal region (a.a. 236–354) (Fig.
3d), also showed interaction with core by the yeast two-
hybrid method (Fig. 1A). The N-terminal portion of NS5A
(a.a. 1–181) and the full-length NS5A showed negligible
or weak binding to core (Fig. 3d). The negative result with
the N-terminal NS5A is consistent with the yeast two-
hybrid assay, but it is not known why the full-length NS5A
failed to be pulled down in this in vitro pull-down assay.
It may be possible that the full-length NS5A was mis-
folded when it was in vitro translated, so that the minimal
region could not be accessible to core. As controls,
pull-down experiments were also done with GST-bound
beads mixed with Ni beads (see Materials and Meth-
ods). None of the NS5A fragments showed any signifi-
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cant binding to the GST protein (Fig. 3c), indicating that
the interaction between core and NS5A is specific to the
core protein.
We confirmed the interaction in mammalian cells by
coimmunoprecipitation (co-IP). COS-7 cells were trans-
fected with pXJ40-flag-core and pXJ40-myc-NS5A, or with
pXJ40-flag-core and pXJ40-myc-NS3 as a negative con-
trol. The cell lysates were incubated with antiflag aga-
rose gel and any immunoprecipitated myc-tagged pro-
tein was detected by Western blotting. NS5A, but not
NS3, was precipitated by flag-core (Fig. 4A). The reverse
co-IP, i.e., precipitating flag-NS5A and detecting for myc-
core, gave poorer signal probably because only a sub-
fraction of NS5A is complexed with core, consistent with
IF data (Fig. 2B).
Co-IP experiments using total cell lysates were done
with fragments of NS5A and core (data not shown). We
found that all three domains of NS5A, the C-terminal (a.a.
147–354), the N-terminal (a.a. 1–181), and the minimal
(a.a. 236–354) domains, were capable of coimmunopre-
cipitating with core (summarized in Fig. 5). Interpretation
of this data was complicated by the nuclear localization
of NS5A fragments in which the N-terminus cytoplasmic
retention signal of the protein is deleted (our observa-
tions; Satoh et al., 2000). C-NS5A and min-NS5A are
localized to the nucleus, as seen by IF, and are therefore
not expected to interact with the cytoplasmically local-
ized core. It is possible that when the cells were lysed,
the nuclear-localized NS5A truncated proteins and the
cytoplasmic core were able to mix and interact with core,
or a small portion of C-NS5A and min-NS5A present in
the cytoplasm but not visible by IF, can interact with the
core protein.
To overcome this complication, we used cytoplasmic
extracts for co-IP (Fig. 4B). Using the method described
by Andrews and Faller (1991), core, full-length, and
N-NS5A were largely found in the membrane fraction
and were not solubilized in the cytoplasmic fraction (data
not shown). The addition of 0.1% Triton X-100 (TX-100) to
Buffer A increased the solubility of core and NS5A pro-
teins, while the nuclei remained intact. PARP1 was used
as a nuclear marker and it was detected in the nuclear
fraction but not the cytoplasmic fraction, indicating that
nuclear proteins were largely not extracted into the cy-
toplasmic fraction (Fig. 4Ba). Core was solubilized, albeit
partially, into the cytoplasmic fraction (Fig. 4Bb). Full-
length NS5A and N-NS5A are localized to the cytoplasm
by IF and were indeed mostly extracted in the cytoplas-
mic fraction (Fig. 4Bc). A small proportion may remain
attached to the nuclei, thus their presence in the nuclear
fraction. Consistent with the localization of C-NS5A and
min-NS5A in the nucleus by IF, these proteins were
partitioned mostly into the nuclear fractions (Fig. 4Cc).
Some C-NS5A and min-NS5A can be detected in the
cytoplasmic fractions, which could be due to the frag-
mentation of nuclei as cells undergo cell death, induced
FIG. 1. (A) A minimal domain of NS5A required for interacting with core was defined using the yeast two-hybrid assay. N- and C-terminal truncations in
NS5A were cloned into pAS2-1. These were transformed into PJ69-2A and transformants were mated with Y187 carrying pACT-core. The resulting diploids
were patched on -TRP-LEU plates, and the patches of cells were allowed to grow for a few days, after which they were replica plated onto -HIS and -ADE
plates and also lifted onto nylon membrane for -gal assay. A fragment from a.a. 236 to 354, which includes the PKR-binding, ISDR, and proline-rich (P-rich)
regions, was defined to be the minimal region required for interaction with core. Positive interactions were indicated by growth on -HIS, and -ADE plates,
and the presence of -gal activity. (B) Full-length core is required for interaction with NS5A. pACT-core constructs were transformed into Y187 and
transformants mated to PJ69-2A carrying pAS-NS5A. Deletion of core at the N- or C-termini abolishes its interaction with NS5A.
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by core. However, judging from the partitioning of PARP1
protein, nuclear proteins should remain in the nuclear
fraction, which suggests that some C-NS5A and min-
NS5A may be present in the cytoplasm. Using cytoplas-
mic extracts for co-IP experiments, we found that the
amount of proteins that coimmunoprecipitated with core
FIG. 2. Colocalization of core and NS5A in COS-7 cells. (A) COS-7 cells were transfected with constructs expressing flag-core or myc-NS5A for
about 14 h. The cells were fixed in methanol and prepared for immunofluorescence. Core is localized in the cytoplasm, around the nucleus, and has
a punctate appearance. NS5A is localized in the perinuclear region and is concentrated usually on one side of the nucleus, similar to ER proteins.
(B) COS-7 cells coexpressing flag-core (green) and myc-NS5A (red) were visualized by confocal microscopy. The staining pattern of each protein when
coexpressed is similar to that of individually expressed proteins, except that the core localization becomes more similar to that of NS5A. The merged
pattern (yellow) shows colocalization of core and NS5A. Bars represent 1 m.
FIG. 3. NS5A fragments binds to core in vitro. GST-core-6His protein was bound to Ni beads and the beads equilibrated in binding buffer. GST
bound to GSH beads, mixed with Ni beads, was used as controls for binding. N-terminally myc-tagged full-length (FL) and truncated NS5A (C-NS5A,
N-NS5A, and min-NS5A) proteins (Fig. 5) were produced by IVT reactions and equal amounts of [35S]met-labeled products (15–18 l of a 40-l
reaction) were added to GST-core-6His-beads and GST beads. The total volume of each mixture was made up to 300 l with binding buffer. The
amounts of bead-bound GST-core-6His and GST proteins used for each binding assay are shown on the Coomassie-stained gel (a). A fraction (about
1/6) of the input IVT products (b), the amounts of IVT products that bound to GST (c), and GST-core-6His (d) are shown in the autoradiographs.
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FIG. 4. (A) Coimmunoprecipitation between core and NS5A. COS-7 cells were transfected with plasmids expressing flag-core and myc-NS5A, or
flag-core and myc-NS3 as a negative control. About 100–150 g of total protein from transfected cells was used for immunoprecipitation using
anti-flag agarose gel. Western blotting of 10 g total protein showed appropriate expression of flag-core (lanes 1 and 2), myc-NS5A (lane 5), and
myc-NS3 (lane 6). NS5A is cleaved to give proteolytic products (indicated by *) when core is coexpressed. Lanes 3 and 4 showed that flag-core was
bound to antiflag beads. In the immunoprecipitates, myc-NS5A, as well as two of the N-terminal fragments of NS5A, could be detected (lane 7), while
NS3 was not precipitated significantly by core (lane 8). (B) Co-IP experiments with cytoplasmic extracts were prepared from COS-7 cells transiently
coexpressing flag-core and myc-NS5A, myc-C-NS5A, myc-N-NS5A or myc-min-NS5A. Cytoplasmic proteins (100–150 g) were used for co-IP
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varied with the amount of each protein in the cytoplasmic
fraction (Fig. 4Be). The full-length NS5A and cleaved
fragments bind to core, with the N-terminal 20-kD frag-
ment showing stronger interaction than longer frag-
ments. N-NS5A contains a cleavage site and is cleaved
to give a 20-kD fragment, which also shows a stronger
association than the larger fragment. The ability of the
N-terminal fragment to associate with core is not con-
sistent with yeast two-hybrid and in vitro binding assays.
It may be possible that in mammalian cells, the N-termi-
nal fragments can interact indirectly with core, through
another unknown cellular protein(s). C-NS5A is present
in small amounts in the cytoplasmic fraction and conse-
quently, very little was precipitated by core. The minimal
fragment of NS5A appears to bind better than N-NS5A, if
the relative amounts of N-NS5A and min-NS5A proteins
in the cytoplasm are taken into account.
Core induces caspase-dependent apoptosis and the
cleavage of NS5A
Core has been shown by several groups to cause
apoptosis (Hahn et al., 2000; Honda et al., 2000; Ruggieri
et al., 1997; Zhu et al., 1998), and NS5A was reported to
be cleaved by caspase-like proteases upon stimulation
by apoptotic signals (Satoh et al., 2000). In the course of
this study, we observed that overexpression of core
causes the cleavage of NS5A to give specific-sized frag-
ments of about 55 and 20 kD. A fainter band of about 35
kD is sometimes detected (Figs. 4, 6, and 7). We also
observed cell death, in core-expressing cells, which
prompted us to investigate if there is a correlation be-
tween core-induced apoptosis and NS5A cleavage.
COS-7 cells were transfected with vector (as control),
pXJ40-flag-core, pXJ40-myc-NS5A, or pXJ40-flag-core to-
gether with pXJ40-myc-NS5A. The overexpression of
core causes apoptosis, as indicated by the cleavage of
PARP1, and DNA laddering (Figs. 6c and 6d), both hall-
marks of apoptosis. NS5A by itself does not cause apop-
tosis and does not significantly enhance the apoptotic
effect of core (Figs. 6c and 6d), indicating that the cleav-
age of NS5A is apparently not important for increasing
cell death within the period of the experiment.
This cleavage pattern was also seen when core and
NS5A were coexpressed in 293 cells (data not shown).
We investigated if the induction of apoptosis and NS5A
cleavage by core is also observed in hepatocarcinoma
cell lines. In Huh7 and HepG2 cells, cell death, PARP1
cleavage, and DNA laddering were not obvious when
core was overexpressed. Although NS5A was cleaved, a
lower proportion was proteolyzed than in COS-7 and 293
cells. This could be due to a low transfection efficiency in
Huh7 cells so that the majority of cells were not express-
ing core and therefore not undergoing apoptosis. SK-
HEP-1 cells, which transfect well, exhibit PARP1 cleav-
age, partial DNA laddering, and NS5A cleavage when
core was overexpressed (Figs. 6e–6h). The DNA in SK-
HEP-1 cells was only cleaved into large molecular
weight fragments (above 10 kb; Fig. 6h) in the presence
of core, possibly due to the absence of certain caspases
that are required for the complete activation of nucleases
that mediate DNA fragmentation. It has been shown that
the breast carcinoma cell line, MCF-7, does not exhibit
some events typical of apoptosis due to the lack of
caspase-3 (Janicke et al., 1998; Tang and Kidd, 1998).
Caspase-3 is required for cleaving and activating DFF45,
the DNAase essential for mediating genomic DNA deg-
radation. A similar cleavage of NS5A by caspases was
reported in Saos-2 cells, an osteocarcinoma-derived cell
line, under apoptotic stimuli (Satoh et al., 2000), indicat-
ing that diverse cell types possess the biochemical path-
ways needed to mediate the phenomena observed.
To determine if core is indeed activating caspases
which then cleave NS5A, we transfected COS-7 cells
with pXJ40-flag-core alone or plasmids expressing flag-
core and myc-NS5A, and added either Z-VAD-FMK, a
caspase inhibitor, or Z-FA-FMK, a negative control which
should not inhibit caspases, to the transfected cells.
Apoptosis-associated events, PARP1 cleavage and DNA
laddering, were inhibited in the presence of Z-VAD-FMK,
but not in the presence of Z-FA-FMK (Figs. 7c and 7d).
experiments and 10–20 g proteins was used for Western blotting. (a) PARP1 was used as a nuclear marker to show that nuclear proteins were
extracted into the nuclear fraction (n) but not extracted into the cytoplasmic (c) fraction. Cytoplasmic and nuclear fractions were detected for flag-core
(b) and myc-tagged proteins (c) to see the proportion of proteins in either fractions. One-tenth and nine-tenth of the proteins bound to antiflag beads
were probed for the presence of flag-core (d) and myc-tagged NS5A proteins (e), respectively.
FIG. 5. Summary of interaction between NS5A fragments and core, using the yeast two-hybrid and in vitro binding assays, and co-IP in COS-7 cells.
Interpretation of the co-IP results must take into account the nuclear localization of C-NS5A and min-NS5A.
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NS5A cleavage was also inhibited by Z-VAD-FMK (Fig.
7b), indicating that core activates apoptosis and thereby
caspases and that caspases are responsible for the
cleavage of NS5A. The amount of core and NS5A de-
tected in cells treated with Z-VAD-FMK were much higher
than control cells, probably because there are more
viable cells actively expressing proteins. The partial
cleavage of NS5A and PARP1 implies incomplete inhibi-
tion of caspases by Z-VAD-FMK, although DNA laddering
is effectively inhibited.
DISCUSSION
We have uncovered a novel interaction between core
and NS5A, using the yeast two hybrid. This interaction
was confirmed by in vitro pull-down assays. The minimal
region of NS5A required for binding with core contains
the ISDR, PKR-binding, and proline-rich regions that par-
ticipate in other protein–protein interactions. This region
may represent a promiscuous sequence that binds to
several proteins. The core-NS5A interaction is likely to
be direct, as shown by the in vitro binding assay. How-
ever, it is possible that the two proteins form a complex
through other proteins, which may explain why the N-
terminal portion of NS5A is able to coimmunoprecipitate
with core, contrary to the yeast two-hybrid and in vitro
binding assay results. Core has been shown to be as-
sociated with lipid droplets (Barba et al., 1997; Morad-
pour et al., 1996), while NS5A is localized to the perinu-
FIG. 6. Core causes apoptosis and cleavage of NS5A. COS-7 (a–d) or SK-HEP-1 (e–h) cells were transfected with vector. pXJ40-flag-core,
pXJ40-myc-NS5A or pXJ40-flag-core, and pXJ40-myc-NS5A. Cells (floating and attached) were harvested about 14 h after transfection and lysed. The
lysates were extracted for protein and DNA. Western blots of equal amounts (20 g each) of protein samples from each transfection were probed
with antiflag (a, e) and anti-myc (b, f) antibodies to show that the core and NS5A proteins were expressed appropriately. Another Western blot was
probed with anti-PARP1 antibody (c, g) to detect the cleavage of PARP1. Equal amounts of DNA were electrophoresed on a 1.5% agarose gel to
visualize DNA laddering (d, h). Cells expressing core and core with NS5A showed PARP1 cleavage (c, g; cleaved PARP1 is indicated by Œ), DNA
laddering (d), and partial DNA degradation (h), indicating that apoptosis had occurred. NS5A is cleaved only when core is coexpressed (b, f). Cleaved
fragments are indicated by *. Cells transfected with vector, or pXJ40-myc-NS5A alone, did not exhibit these indicators of apoptosis.
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clear region, probably to ER membranes. Using confocal
microscopy, we could detect a subfraction of NS5A co-
localized with core, suggesting that NS5A may also be
localized to lipid droplets.
The function of the core–NS5A interaction for viral
assembly or replication is not clear. It has not been
reported before that NS5A is incorporated into the viral
particle during assembly, and core does not appear to
have a role in viral RNA replication. However, core binds
specifically to the 5 NCR of the HCV genome and could
suppress its translation (Fan et al., 1999; Shimoike et al.,
1999). Alternatively, core–NS5A may couple viral replica-
tion to viral assembly, since NS5A is likely to be involved
in replication and core is the nucleocapsid protein that
binds the viral RNA.
Binding between the two proteins is apparently not
necessary for cleavage of NS5A, as other apoptotic sig-
nals can induce NS5A cleavage (Satoh et al., 2000) in the
absence of core. However, cells infected with the HCV
will express core, which could provide an intrinsic
apoptotic signal. This signal is dependent on the level of
core protein expressed in the cell: cells expressing a low
level of core do not show any sign of apoptosis (our
observation), while overexpression of core under a
strong promoter such as the CMV promoter causes
apoptosis. In cells infected with HCV, the level of core
may not be high enough to induce programmed cell
death, but other factors such as cytokine stimulation (Zhu
et al., 1998; You et al., 1999a) and the activation of certain
signal transduction pathways such as those involving
Fas signaling (Ruggieri et al., 1997) could enhance the
proapoptotic signal of core.
NS5A modulates cell-cycle regulatory genes and pro-
motes cell growth (Ghosh et al., 1999). Coexpression of
NS5A with core does not reduce apoptosis. This is seen
by the similar degree of PARP1 cleavage and DNA lad-
dering compared to cells transfected with pXJ40-flag-
core alone (Figs. 6 and 7). It is not evident from these
observations that NS5A modulates the apoptotic effect of
core.
Apoptosis of cells infected with viruses may appear
suicidal to the viruses that induce programmed cell
death of its host. However, apoptosis has been sug-
gested to be an innate response to virus infection (re-
viewed by Everett and McFadden, 1999) as a means of
facilitating virus dissemination. Apoptotic cell death also
avoids inflammation and cytotoxic T cell response,
thereby circumventing detection by the host immune
surveillance system (reviewed by Roulston et al., 1999).
Several studies report conflicting effects of core on
apoptosis; these may reflect different responses of the
cells to core during different stages of viral replication.
Core could serve as a versatile signal to induce or inhibit
apoptosis, depending on the status of the replication
cycle of the virus. For instance, viruses undergoing early
phases of replication may block apoptosis, while mature
viruses may induce apoptosis to release viral particles
for reinfection.
Both core and NS5A are normally localized in the
cytoplasm, although several studies implicated both pro-
teins in transcriptional regulation. Their role in transcrip-
tional activation may be direct, or indirect, through their
interaction with other cellular proteins. For both proteins
to directly activate transcription, they need to be trans-
located into the nucleus. This may be made possible by
the deletion of regions of NS5A and core that contain the
FIG. 7. Cleavage of NS5A can be inhibited by Z-VAD-FMK. Two plates of COS-7 cells were transfected with pXJ40-flag-core and another two were
cotransfected with constructs expressing flag-core and myc-NS5A. For each transfection, one of the two plates was treated with 20 M Z-VAD-FMK,
a caspase inhibitor, while the other was treated with 20 M Z-FA-FMK, a negative control. About 14 h after transfection, all cells were collected and
the lysates extracted for protein and DNA. Equal amounts of protein extracts (20 g each) were detected for the expression of flag-core (a), myc-NS5A
(b), and the cleavage of PARP1 (c; cleaved PARP1 is indicated by Œ) by Western blotting. DNA samples were electrophoresed to visualize DNA
laddering (d). Z-VAD-FMK inhibited events typical of apoptosis, such as PARP1 cleavage and DNA laddering, as well as the cleavage of NS5A (cleaved
NS5A fragments are indicated by *.
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cytoplasmic retention signal (Ravaggi et al., 1994; Suzuki
et al., 1995; Satoh et al., 2000). For NS5A, the cleavage by
caspases produces N-terminally deleted forms that can
enter the nucleus and therefore act as transcription ac-
tivators. We and others (Satoh et al., 2000) have not been
able to detect nuclear localized NS5A with the anti-NS5A
monoclonal antibody used (data not shown) in the pres-
ence of an apoptotic stimulus, but that may be due to
limitations of detection by immunofluorescence. Core,
when expressed in mammalian cells, is truncated at the
C-terminus (Figs. 4, 6, and 7; Liu et al., 1997; Yasui et al.,
1998), which should remove the hydrophobic tail that
localizes core to the cytoplasm. We could not detect
nuclear-localized core in our immunofluorescence ex-
periments, possibly because full-length core complexes
with the truncated core and prevents the truncated core
from being transported to the nucleus (Liu et al., 1997).
However, when NS5A and core are coexpressed, NS5A
could compete with core–core self-interaction and N-
terminal-deleted NS5A may bring a fraction of C-termi-
nal-deleted core into the nucleus. Fractionation methods
to separate nuclear proteins from cytoplasmic proteins
cannot definitively determine the presence of nuclear-
localized NS5A protein as nuclear fractions are inadver-
tently contaminated by cytoplasmic or membrane-asso-
ciated proteins. Failure to detect nuclear-localized forms
of NS5A and core by IF does not exclude the possibility
that small amounts of these proteins are sufficient to
affect transcription of certain genes that may lead to
pathogenesis in the long term. The identification of
genes that are regulated by NS5A and core individually
or in combination would be of interest for the under-
standing of HCV-related pathology.
MATERIALS AND METHODS
Construction of plasmids
Core- and NS5A-coding DNA sequences, amplified
from HCV-positive serum, were used as templates for
generating core and NS5A clones for this work. Se-
quence analysis showed that the HCV isolate we have
cloned, called HCV-S1, is most closely related to the 1b
strain (Lim et al., 2001). For the yeast two-hybrid interac-
tion assays, NS5A and core clones were fused in frame
with the Gal4 DNA binding domain (BD) and the Gal4
activating domain (AD) in pAS2-1 and pACT2 vectors
(Clontech), respectively. For expression in mammalian
cells, core and NS5A fragments were cloned in pXJ40-
myc and pXJ40-flag vectors which were derived from
pXJ40 (Xiao et al., 1991). Plasmids used in this study are
summarized in Table 1. For expressing GST-core-6His in
bacteria, core was cloned in frame with the GST moiety
in the pGEX-4T-1 (Pharmacia) vector, and then the frag-
TABLE 1
Plasmids Used in This Study
Plasmid Description Source
pAS2-1 Gal4 DNA-binding domain in a 2, TRP1, yeast shuttle vector Clonetech Inc.
pACT2 Gal4 activation binding domain in 2, LEU2, yeast shuttle vector Clonetech Inc.
pFG5 pACT-core (a.a. 1–191) This work
pFG71 pAS-NS5A (a.a. 1–415) This work
pFG107 pXJ40-flag-core This work
pFG115 pXJ40-myc-NS5A This work
pFG213 pAS-NS5A-N-RI (a.a. 147–415) This work
pFG214 pACT-core-C-NarI (a.a. 1–140) This work
pFG215 pACT-C-N-SmaI (a.a. 79–191) This work
pFG233 pAS-NS5A-C-ScaI (a.a. 1–181) This work
pFG244 pAS-NS5A-C-BamHI (a.a. 1–374) This work
pFG245 pAS-NS5A-C-SalI (a.a. 1–354) This work
pFG246 pAS-NS5A (a.a. 236–316) This work
pFG247 pAS-NS5A-min (a.a. 236–354) This work
pFG248 pAS-NS5A (a.a. 277–316) This work
pFG249 pAS-NS5A (a.a. 277–354) This work
pFG325 pXJ40-myc-min-NS5A (a.a. 236–354) This work
pFG326 pXJ40-myc-C-NS5A (a.a. 147–354) This work
pFG330 pXJ40-myc-N-NS5A (a.a. 1–181) This work
pFG250 pGEX-core-6His This work
pXJ40 Mammalian expression vector with CMV promoter, Kozak sequence and SV40 poly(A) termination signal Xiao et al., 1991
pXJ40-myc Mammalian expression vector for tagging proteins with c-myc at N-terminus V. Yu Lab, IMCB
pXJ40-flag Mammalian expression vector for tagging proteins with flag at N-terminus Glaxo Lab, IMCB
pGEX-4T-1 GST-fusion expression vector Pharmacia
pQE60 Expression vector with 6-His tag Qiagen
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ment encoding the fusion protein GST-core was trans-
ferred to a pQE60 vector (Qiagen).
Tissue culture
COS-7 cells (green monkey kidney fibroblasts), 293
cells (transformed human kidney fibroblasts), and Huh7
cells (a human hepatocarcinoma cell line) were main-
tained in standard DME medium supplemented with 10%
fetal calf serum (HyClone Laboratories) and antibiotics
penicillin at 10 u/ml and streptomycin at 100 g/ml
(Sigma). Two other cell lines of liver origin, HepG2 (he-
patocellular carcinoma) and SK-HEP-1 (liver adenocarci-
noma), were grown in MEM medium containing 2 mM
L-glutamine 1.5 g/L sodium bicarbonate, 0.1 mM nones-
sential amino acids, 1.0 mM sodium pyruvate, penicillin
at 10 u/ml, streptomycin at 100 g/ml 10% fetal bovine
serum. COS-7, 293, HepG2, and SK-HEP-1 cells were
obtained from American Type Culture Collection (ATCC),
while Huh-7 cells were obtained from Japan Health Sci-
ences Foundation (Chou-ku, Osaka, Japan).
Manipulation of yeast and yeast two-hybrid assays
Manipulation of yeast for two-hybrid assays was done
as described in the Matchmaker User Manual (Clon-
tech). In this system, the presence of an interaction
between two viral proteins was indicated by the activa-
tion of the reporter genes, HIS3 and ADE2, which allow
for growth on -HIS and -ADE media, respectively, and
LACZ, a -galactosidase (-gal) that produces a blue
color when the substrate X-gal (Sigma) is cleaved. The
activation of these three reporters indicates the strength
of the interactions, with LacZ and Ade indicating stron-
ger interaction than the His phenotype. The pAS2-1 and
pACT2 constructs were transformed into PJ69-2A (MATa,
trp1-901, leu2-3,112, ura3-52, his3-200, ade2-101, gal4,
gal80, LYS2::GALUAS-GAL1TATA-HIS3, GAL2UAS-GAL2TATA-
ADE2) and Y187 (MAT, trp1-901, leu2-3,112, ura3-52,
his3-200, ade2-101, gal4, gal80, met URA3::GALUAS-
GAL1TATA-LACZ), respectively. To test for interaction, the
two strains carrying various fragments of core and
NS5A were mated on YEPD plates and then transferred
onto -TRP-LEU plates to select for diploids that have both
plasmids. They were then replica-plated onto -TRP-LEU-
HIS and -TRP-LEU-ADE plates and also assayed for
-gal activity. We confirmed the interactions by retrans-
forming the pairs of constructs into the haploid strains
PJ69-2A and Y187 and assaying for the activation of the
appropriate reporter genes. -gal activity assays were
performed as described in Khu et al. (2001).
In vitro binding assay
GST-core, when expressed in bacteria, was truncated,
and core-6His gave poor yield. We found that fusing a
GST moiety to the N-terminus and six His residues at the
C-terminus of core gave good expression and renders
the protein more soluble during extraction. An overnight
culture of the bacterial strain carrying the pQE60 plasmid
for the expression of GST-core-6His protein was diluted
1:100 in 50 ml and grown to an OD 600 of about 0.8–1.0.
The cells were pelleted and the pellets frozen at 70°C
for later use. The cell pellet was lysed by sonication in 10
ml PBS with 5 mM imidazole. The lysate was centrifuged
for 40 min at 16,000 rpm and the cleared supernatant
incubated overnight with rolling, with 1 ml Ni-NTA aga-
rose slurry (Qiagen) equilibrated in PBS containing 5 mM
imidazole. The beads were washed five times in PBS/
imidazole, and the amount and quality of the bound
GST–core proteins visualized on an SDS–PAGE gel.
About 1 g of bound fusion protein was used per in vitro
binding experiment. As a control, GST was expressed
from the pGEX-4T-1 vector and the protein bound to
glutathione (GSH) Sepharose 4B beads (Amersham
Pharmacia). As the concentration of GST protein bound
to beads was very high, Ni agarose was added to
make up the volume similar to that of GST-core-6His
beads used for the binding reaction.
NS5A fragments cloned into a pXJ40-myc vector, which
has a T7 promoter, were in vitro transcribed and trans-
lated (IVT) to produce [35S]methionine-labeled proteins,
using a T7 polymerase-driven transcription–translation
kit (Promega). IVT products, which had a myc-tag at the
N-terminus (about 15–18 l of a 40 l reaction), were
added to the beads with GST-core-6His or GST proteins
bound, and the volumes made up to 300 l with binding
buffer (PBS with 0.1% TX-100). The mixture was rolled
gently at room temperature for about 1 h and then
washed five times with cold binding buffer. The proteins
bound to the beads were extracted by boiling in sample
buffer and separated on SDS–PAGE gels. The gels were
fixed in fixative (50% methanol, 10% acetic acid, 40%
water) for 20 min and then soaked in Amplify (Amersham)
for 20 min. The gels were dried and exposed to X-ray film
(Hyperfilm) overnight at room temperature.
Immunofluorescence
Sterile polylysine-coated coverslips (Iwaki, Japan)
were placed in tissue culture dishes before the COS-7
cells were plated on them. The cells were transfected
and after about 14 h, the coverslips were lifted off the
plates, rinsed once with PBS, and then placed in 100%
methanol at 20°C for 5 min. The coverslips were air-
dried completely and rehydrated in PBS-CM-NH4Cl (1
mM CaCl2, 1 mM MgCl2, 0.3% NH4Cl in PBS) and then in
BSA/PBS (1% BSA in PBS). Coverslips were placed with
the cells facing down, onto a small drop of 1° Ab [1:100
monoclonal antiflag (Sigma), 1:100 polyclonal anti-myc
(Santa Cruz Biochemicals)] for 1 h or more at room
temperature. The coverslips were washed three times
with 1 ml BSA/PBS. Secondary antibodies (1:100 FITC-
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conjugated anti-mouse IgG, 1:100 TRITC-conjugated
anti-rabbit IgG; Santa Cruz Biochemicals) were then ap-
plied on the cells (as above) for at least 1 h, room
temperature. After washing, the coverslips were
mounted in antifade mounting medium and the staining
was visualized on a confocal microscope (Bio-Rad).
Immunoprecipitation (IP)
COS-7 cells were transfected using Effectene (Qiagen)
according to supplier’s instructions. About 14 h after
transfection, cells in media and on the plates were har-
vested and lysed in lysis buffer (0.5% TX-100 in PBS with
1 mM EDTA, 1 mM EGTA, 0.4 mM PMSF) at 4°C. Total
cell lysate (100–150 g) was incubated (with rolling) with
10 l packed anti-flag-agarose gel (Sigma) for 1 h or
more at room temperature. The gel was washed five
times, each with 1 ml lysis buffer, and the proteins bound
to the gel were extracted by boiling for 2 min in 5
sample buffer and separated by SDS–PAGE.
Preparation of cytoplasmic extracts
Transfected COS-7 cells from a 6-cm plate were har-
vested according to Andrews and Faller, 1991, and the
cytoplasm extracted twice, each in 75 l cold Buffer A
containing 0.1% TX-100. The lysate were spun at 1000 g
for 5 min in the cold and the supernatant from the two
extractions pooled. The pellet, which contains nuclei and
some membrane attached to the nuclei, was resus-
pended in 150 l Buffer A with 0.1% TX-100. Cytoplasmic
proteins (10–20 g) and equivalent volumes of nuclear
fractions were used for Western blotting, and 100–150 g
of cytoplasmic proteins was used for co-IP experiments.
Assays for apoptosis
For these experiments, COS-7 cells plated on 9-cm
dishes were transfected with 2 g of each plasmid. Cells
floating in the growth medium and attached on the plates
were harvested and lysed in lysis buffer (see above)
14–15 h posttransfection. The lysate was divided into two
portions, one was extracted for DNA according to Ronca
et al., 1997; the other was extracted for protein. DNA
samples were electrophoresed on 1.5% agarose gel. The
gel was destained in water to remove loading dye and
excess ethidium bromide and DNA laddering was visu-
alized by UV illumination. Protein samples were Western
blotted and PARP1 cleavage was detected with an anti-
PARP1 monoclonal antibody. Anti-PARP1 polyclonal anti-
bodies were obtained from CHUL Research Center, Can-
ada, or Santa Cruz Biochemicals. These two antibodies
gave cross-reacting bands with different molecular
weights relative to PARP1 (Figs. 6 and 7).
Z-VAD-FMK, a peptide cysteine protease inhibitor, and
Z-FA-FMK, a negative control (Enzyme Systems Prod-
ucts), were dissolved in DMSO at a concentration of 20
mM. In apoptosis inhibition experiments, the compounds
were diluted 200-fold in media before adding dropwise to
cells immediately after transfection to a final concentra-
tion of 20 M.
Western blot analysis
Protein samples were resolved by SDS–PAGE, trans-
blotted onto Hybond-C membranes (Amersham), and
then probed with anti-flag monoclonal (1:1000 dilution;
Sigma), anti-myc monoclonal (1:1000 dilution), or anti-
myc polyclonal (1:500 dilution; Santa Cruz Biochemicals)
antibodies overnight at 4°C or at least 1 h at room
temperature. After extensive washes, a secondary anti-
body conjugated to horseradish peroxidase (1:5000 dilu-
tion; Pierce) was applied onto the blots for at least 1 h at
room temperature. Antibodies were diluted in PBS with
1% skimmed milk and 0.05% Tween 20. Blots were
washed four to five times with PBS with 0.05% Tween 20,
each for at least 5 min. Reagents for enhanced chemi-
luminescence (Pierce) were applied to the blots and the
light signals detected by exposing the blots to X-ray film
(Hyperfilm).
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